KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

Elanco Animal Health (ELAN) Receivables - Net (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Receivables - Net for 9 consecutive years, with $873.0 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 8.45% to $873.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $873.0 million through Dec 2025, up 8.45% year-over-year, with the annual reading at $873.0 million for FY2025, 8.45% up from the prior year.
  • Receivables - Net hit $873.0 million in Q4 2025 for Elanco Animal Health, down from $894.0 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $1.1 billion in Q2 2021 to a low of $797.0 million in Q4 2022.
  • Historically, Receivables - Net has averaged $925.2 million across 5 years, with a median of $920.0 million in 2021.
  • Biggest five-year swings in Receivables - Net: skyrocketed 96.18% in 2021 and later fell 14.15% in 2022.
  • Year by year, Receivables - Net stood at $833.0 million in 2021, then dropped by 4.32% to $797.0 million in 2022, then rose by 5.65% to $842.0 million in 2023, then decreased by 4.39% to $805.0 million in 2024, then rose by 8.45% to $873.0 million in 2025.
  • Business Quant data shows Receivables - Net for ELAN at $873.0 million in Q4 2025, $894.0 million in Q3 2025, and $989.0 million in Q2 2025.